prader willi glp 1 agonist Novel therapeutics in rare genetic obesities: A narrative review GLP-1 Drug Savings: A Complete

McGraw-Hill / Lange rxlist.com (Tragenta ) Alogliptin Trade Name: Nesina Mechanism of Action: a DPP-4 inhibitor, similar to Sitagliptin Pharmacokinetics: does not undergo significant metabolism, and is mostly excreted unchanged in the urine (76%) and feces (13%) dosage should be reduced in patients with moderate to severe renal impairment References: Masharani U, Kroon L (2024): Pancreatic Hormones & Antidiabetic Drugs (Chapter 41)

They therefore could not be sure if it was identical to the human GLP-1 sequence documented by Bell

But the very qualities that make GLP-1s such powerful tools for weight loss also make them potentially dangerous for those who struggle to adequately feed themselves

Some physicians prescribe phentermine for longer periods

While Li et al

FI: Writing original draft